URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Peter Kouides

Concepts (298)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Menorrhagia
21
2001
28
7.130
Why?
von Willebrand Diseases
15
1998
22
5.600
Why?
Hemostasis
8
1998
62
3.390
Why?
Hemophilia A
7
2009
30
2.840
Why?
Hemorrhage
9
2001
180
2.770
Why?
Blood Coagulation Disorders
8
2002
37
1.920
Why?
Menstruation
6
1998
16
1.510
Why?
Coagulants
2
2008
13
1.480
Why?
Antifibrinolytic Agents
5
2008
18
1.390
Why?
Hemostatics
6
2006
23
1.340
Why?
Humans
72
1988
36274
1.200
Why?
Delivery of Health Care
2
2009
146
1.200
Why?
Physician's Practice Patterns
2
2009
243
1.130
Why?
Heparin
2
2005
122
1.120
Why?
Tranexamic Acid
4
2008
7
1.100
Why?
Factor VIII
4
2009
50
1.080
Why?
Anticoagulants
2
2005
135
1.080
Why?
Deamino Arginine Vasopressin
5
2006
23
1.080
Why?
Factor X Deficiency
2
2001
2
1.060
Why?
Blood Coagulation Factors
5
2001
50
0.990
Why?
Uterine Hemorrhage
2
2004
26
0.980
Why?
Female
43
1993
19838
0.960
Why?
Hemophilia B
2
2009
12
0.910
Why?
Biopsy
2
2006
362
0.880
Why?
Myelodysplastic Syndromes
5
1992
131
0.880
Why?
Blood Loss, Surgical
2
2008
44
0.860
Why?
Antibodies, Monoclonal
2
2006
711
0.840
Why?
Blood Platelet Disorders
3
2004
7
0.780
Why?
Thrombosis
1
2012
200
0.710
Why?
Polyps
1
2009
9
0.710
Why?
Factor IX
1
2009
11
0.710
Why?
Perioperative Care
1
2009
23
0.710
Why?
Postoperative Hemorrhage
1
2009
19
0.700
Why?
Purpura, Thrombocytopenic
3
1995
15
0.690
Why?
Colonoscopy
1
2009
44
0.690
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2008
92
0.690
Why?
Venous Thromboembolism
1
2009
25
0.680
Why?
Gastrointestinal Hemorrhage
1
2009
84
0.670
Why?
Factor X
1
2008
16
0.660
Why?
Platelet Function Tests
5
2004
15
0.640
Why?
Pregnancy Complications, Hematologic
4
2001
29
0.640
Why?
von Willebrand Factor
5
2008
59
0.630
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1993
429
0.630
Why?
Adult
27
1988
11351
0.620
Why?
Lymphoma, T-Cell
1
2007
11
0.600
Why?
Registries
1
2008
223
0.600
Why?
Splenic Neoplasms
1
2007
11
0.600
Why?
Crohn Disease
1
2007
88
0.580
Why?
Women
1
2006
17
0.550
Why?
Prostatic Neoplasms
1
2012
555
0.550
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2006
4
0.550
Why?
Liver Neoplasms
1
2007
151
0.540
Why?
Prevalence
4
2005
562
0.540
Why?
Leukemia, Myeloid, Acute
2
1999
177
0.510
Why?
Hysterectomy
1
2004
32
0.490
Why?
Embolization, Therapeutic
1
2004
39
0.480
Why?
Endometrium
1
2004
47
0.480
Why?
Thrombocytopenia
1
2005
74
0.480
Why?
Quality of Life
6
2000
502
0.460
Why?
Middle Aged
20
1993
9837
0.450
Why?
Catheter Ablation
1
2004
73
0.450
Why?
Male
23
1988
19675
0.420
Why?
Child
9
1995
4155
0.420
Why?
Treatment Outcome
7
1993
2615
0.380
Why?
Pregnancy
7
1998
1966
0.380
Why?
Genitalia, Female
1
2000
22
0.380
Why?
Genital Diseases, Female
1
2000
32
0.370
Why?
Administration, Oral
3
2009
308
0.370
Why?
6-Aminocaproic Acid
2
2009
8
0.370
Why?
Adolescent
10
1993
4766
0.370
Why?
Bone Marrow Transplantation
6
1993
197
0.370
Why?
Rare Diseases
2
2008
27
0.360
Why?
Antineoplastic Agents
1
2006
619
0.360
Why?
Young Adult
5
2008
1059
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
1995
44
0.340
Why?
Forecasting
2
2009
177
0.330
Why?
Cytarabine
2
1995
89
0.320
Why?
Mass Screening
3
2006
247
0.310
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
1993
55
0.310
Why?
Blood Coagulation Tests
2
2004
36
0.290
Why?
Sulfhemoglobinemia
1
1996
1
0.280
Why?
Cyanosis
1
1996
5
0.280
Why?
Methylene Blue
1
1996
12
0.280
Why?
Flutamide
1
1996
27
0.280
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.270
Why?
Antineoplastic Agents, Hormonal
1
1996
46
0.270
Why?
Blast Crisis
1
1995
18
0.270
Why?
Clinical Laboratory Techniques
2
2002
38
0.260
Why?
Red-Cell Aplasia, Pure
1
1995
9
0.260
Why?
Cell Transformation, Neoplastic
2
1995
137
0.260
Why?
Questionnaires
4
2000
1004
0.260
Why?
Leukemia, Lymphoid
1
1995
63
0.260
Why?
Leukemia, Myelomonocytic, Chronic
1
1995
19
0.260
Why?
Pericarditis
1
1995
11
0.260
Why?
Aged
11
1993
7269
0.250
Why?
Chromosomes, Human, Pair 14
1
1994
15
0.250
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.250
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.250
Why?
Chromosomes, Human, Pair 1
1
1994
25
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1995
82
0.240
Why?
Burkitt Lymphoma
1
1994
52
0.240
Why?
Translocation, Genetic
1
1994
63
0.240
Why?
Leukemia
1
1995
158
0.240
Why?
Postpartum Hemorrhage
3
2006
8
0.240
Why?
Respiratory Distress Syndrome, Adult
1
1995
75
0.230
Why?
Contraceptives, Oral, Combined
2
2008
5
0.230
Why?
Immunosuppressive Agents
1
1995
200
0.230
Why?
Practice Guidelines as Topic
3
2009
302
0.220
Why?
Sex Characteristics
2
2001
138
0.220
Why?
Retrospective Studies
4
1995
2267
0.210
Why?
Blood Coagulation Factor Inhibitors
1
2012
1
0.210
Why?
Chicago
1
2012
6
0.210
Why?
Hematology
2
2002
13
0.210
Why?
Factor Xa
1
2012
21
0.210
Why?
Charcoal
1
2012
17
0.210
Why?
Antidotes
1
2012
17
0.210
Why?
Congresses as Topic
1
2012
32
0.210
Why?
Blood Coagulation Disorders, Inherited
1
2011
1
0.200
Why?
Prostate-Specific Antigen
1
2012
114
0.200
Why?
Thrombin
1
2012
132
0.190
Why?
Hemorrhagic Disorders
1
2011
4
0.190
Why?
Epistaxis
1
2010
4
0.190
Why?
Hormone Replacement Therapy
1
2011
15
0.190
Why?
Contusions
1
2010
19
0.190
Why?
Immune Tolerance
1
2011
144
0.190
Why?
Remission Induction
2
1995
161
0.180
Why?
Medical History Taking
1
2010
62
0.180
Why?
Vitamin K
1
2009
8
0.180
Why?
Upper Gastrointestinal Tract
1
2009
1
0.180
Why?
Helicobacter Infections
1
2009
7
0.180
Why?
Premedication
1
2009
20
0.180
Why?
Labor, Obstetric
2
1998
32
0.170
Why?
Platelet Transfusion
1
2010
85
0.170
Why?
Cyclooxygenase 2 Inhibitors
1
2009
63
0.170
Why?
Biomedical Research
1
2011
139
0.170
Why?
Administration, Intranasal
1
2009
61
0.170
Why?
Iran
1
2008
4
0.170
Why?
Deferoxamine
1
1988
16
0.170
Why?
Headache
1
2009
50
0.170
Why?
Italy
1
2008
22
0.170
Why?
Plasma
1
2008
33
0.160
Why?
Cross-Over Studies
1
2009
128
0.160
Why?
Prospective Studies
3
1993
1689
0.160
Why?
Disease Management
3
2002
26
0.160
Why?
Homozygote
1
2008
97
0.160
Why?
Great Britain
1
2008
97
0.160
Why?
Heterozygote
1
2008
125
0.160
Why?
Risk Factors
2
1998
2345
0.160
Why?
Mutation, Missense
1
2008
87
0.150
Why?
Placenta Diseases
1
2007
18
0.150
Why?
Diagnosis, Differential
3
1997
874
0.150
Why?
Evidence-Based Medicine
1
2009
202
0.150
Why?
Follow-Up Studies
3
1995
1855
0.150
Why?
Hematologic Tests
1
2007
9
0.150
Why?
Mastocytosis, Systemic
1
2007
4
0.150
Why?
Pneumonia, Pneumocystis
1
1988
119
0.150
Why?
Arteries
1
2007
78
0.150
Why?
Genotype
1
2008
490
0.150
Why?
Recombinant Proteins
1
2009
723
0.140
Why?
Infant
2
2008
2278
0.140
Why?
Menstruation Disturbances
1
2006
8
0.140
Why?
Randomized Controlled Trials as Topic
2
2004
411
0.140
Why?
Placenta
1
2007
146
0.140
Why?
Pain
1
2009
382
0.140
Why?
Lymphoma
2
1993
162
0.130
Why?
Injections, Intravenous
1
2006
131
0.130
Why?
Severity of Illness Index
2
1993
922
0.130
Why?
Antibodies, Monoclonal, Murine-Derived
1
2006
114
0.130
Why?
Lymphoma, Follicular
1
2006
54
0.130
Why?
Lymphoma, Non-Hodgkin
2
1995
113
0.130
Why?
Anti-Inflammatory Agents
1
2006
110
0.120
Why?
Dexamethasone
1
2006
181
0.120
Why?
Postoperative Period
1
2004
84
0.120
Why?
Heavy Chain Disease
1
2003
2
0.120
Why?
Immunoglobulin lambda-Chains
1
2003
19
0.120
Why?
Amyloidosis
1
2003
28
0.120
Why?
Thalassemia
2
1988
23
0.120
Why?
Immunoglobulin Heavy Chains
1
2003
45
0.110
Why?
Infant, Newborn
1
2008
1844
0.110
Why?
Skin
1
2006
377
0.110
Why?
Hodgkin Disease
2
1993
155
0.110
Why?
Child, Preschool
4
1997
2660
0.110
Why?
Premenopause
1
2002
13
0.100
Why?
Postmenopause
1
2002
43
0.100
Why?
Physical Examination
1
2002
87
0.100
Why?
Obstetric Labor Complications
1
2001
20
0.100
Why?
Home Infusion Therapy
1
2001
1
0.100
Why?
Transplantation, Homologous
2
1995
276
0.090
Why?
Prognosis
3
1993
1083
0.090
Why?
Meninges
1
1999
21
0.090
Why?
Fatal Outcome
2
1996
104
0.090
Why?
Flow Cytometry
2
1995
603
0.080
Why?
Multiple Myeloma
1
1999
76
0.080
Why?
Platelet Aggregation
2
2007
66
0.080
Why?
Meningeal Neoplasms
1
1999
50
0.080
Why?
Corynebacterium Infections
1
1998
8
0.080
Why?
United States
3
2011
2688
0.080
Why?
Parvoviridae Infections
1
1998
11
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
Algorithms
1
2002
541
0.080
Why?
Risk Assessment
3
2002
884
0.080
Why?
Cohort Studies
2
2011
969
0.080
Why?
Anemia, Sideroblastic
1
1997
9
0.070
Why?
Copper
1
1997
54
0.070
Why?
Methemoglobinemia
1
1996
1
0.070
Why?
Anemia
1
1997
78
0.070
Why?
Brain Neoplasms
1
1999
281
0.070
Why?
Aged, 80 and over
2
1995
2529
0.070
Why?
Treatment Failure
1
1996
128
0.070
Why?
Sex Factors
1
1998
597
0.070
Why?
Daunorubicin
1
1995
25
0.070
Why?
Hypersensitivity, Delayed
1
1996
49
0.070
Why?
Case-Control Studies
2
2004
617
0.070
Why?
Recurrence
4
1993
691
0.070
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
1995
11
0.070
Why?
Clinical Trials as Topic
2
2008
671
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
42
0.070
Why?
Drug Hypersensitivity
1
1996
37
0.070
Why?
Cyclophosphamide
1
1996
174
0.070
Why?
Immunophenotyping
1
1995
114
0.060
Why?
Hepatitis B
1
1995
18
0.060
Why?
Neoplasm Metastasis
1
1996
228
0.060
Why?
Hydroxyquinolines
1
1993
9
0.060
Why?
Acute Disease
2
1995
586
0.060
Why?
Bone Marrow
1
1994
287
0.060
Why?
Adjuvants, Immunologic
1
1993
117
0.050
Why?
Apoptosis
1
1999
823
0.050
Why?
Stem Cell Transplantation
1
1993
110
0.050
Why?
Drug Monitoring
1
2012
41
0.050
Why?
Drug Interactions
1
2012
183
0.050
Why?
Contraceptive Agents, Female
1
2011
3
0.050
Why?
Drug Combinations
1
2011
148
0.050
Why?
Hematologic Diseases
1
2011
39
0.050
Why?
Hematopoiesis
1
1992
129
0.050
Why?
Menstrual Cycle
1
2011
13
0.050
Why?
Transplantation, Autologous
3
1993
144
0.050
Why?
Protein C
1
2011
31
0.050
Why?
Population Surveillance
1
2011
136
0.050
Why?
Electrocardiography
1
1995
773
0.040
Why?
Longitudinal Studies
1
2011
395
0.040
Why?
Decision Trees
1
2009
29
0.040
Why?
Joint Diseases
1
2009
31
0.040
Why?
Liver Diseases
1
2009
80
0.040
Why?
Intrauterine Devices, Medicated
1
2008
1
0.040
Why?
Levonorgestrel
1
2008
3
0.040
Why?
Danazol
1
2008
4
0.040
Why?
Phenotype
1
2011
763
0.040
Why?
Kidney Failure, Chronic
1
2009
122
0.040
Why?
Progestins
1
2008
15
0.040
Why?
Hypertension, Malignant
1
2007
6
0.040
Why?
Purpura, Thrombotic Thrombocytopenic
1
2007
11
0.040
Why?
Hemostasis, Surgical
1
2008
12
0.040
Why?
Plasmapheresis
1
2007
26
0.040
Why?
ADAM Proteins
1
2007
14
0.040
Why?
Ticlopidine
1
2007
6
0.040
Why?
Gonadotropin-Releasing Hormone
1
2008
43
0.040
Why?
Plasma Exchange
1
2007
18
0.040
Why?
Pre-Eclampsia
1
2007
26
0.040
Why?
Comorbidity
1
2009
380
0.040
Why?
Aspirin
1
2007
59
0.040
Why?
Platelet Aggregation Inhibitors
1
2007
61
0.040
Why?
Drug Resistance
1
2007
102
0.040
Why?
Prednisone
1
2007
165
0.040
Why?
Drug Therapy, Combination
1
2007
382
0.040
Why?
Cardiovascular Diseases
1
2009
277
0.030
Why?
Coagulation Protein Disorders
1
2004
2
0.030
Why?
Fluorescent Antibody Technique, Direct
1
2003
8
0.030
Why?
Basement Membrane
1
2003
32
0.030
Why?
Kidney Glomerulus
1
2003
26
0.030
Why?
Nephrotic Syndrome
1
2003
27
0.030
Why?
Amyloid
1
2003
20
0.030
Why?
Reference Values
1
2004
439
0.030
Why?
Neoplasms
1
2009
739
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2003
131
0.030
Why?
Combined Modality Therapy
2
1993
486
0.030
Why?
Sensitivity and Specificity
1
2004
905
0.020
Why?
Granulocytes
1
1999
80
0.020
Why?
Bone Marrow Examination
1
1998
23
0.020
Why?
Blood Cell Count
1
1998
45
0.020
Why?
Radiotherapy
1
1999
198
0.020
Why?
Bone Marrow Cells
1
1998
221
0.020
Why?
Cerebral Cortex
1
1999
248
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Skin Tests
1
1996
29
0.020
Why?
Immunoglobulin E
1
1996
51
0.020
Why?
Hepatitis B e Antigens
1
1995
3
0.020
Why?
Hepatitis B Surface Antigens
1
1995
7
0.020
Why?
Multivariate Analysis
1
1997
541
0.020
Why?
Antibodies
1
1996
212
0.020
Why?
Disease-Free Survival
1
1995
198
0.020
Why?
Actuarial Analysis
1
1993
21
0.010
Why?
Leukemia, Myeloid
1
1995
119
0.010
Why?
Survival Rate
1
1995
618
0.010
Why?
Proportional Hazards Models
1
1993
450
0.010
Why?
Predictive Value of Tests
1
1993
606
0.010
Why?
Age Factors
1
1995
1128
0.010
Why?
Survival Analysis
1
1993
606
0.010
Why?
Time Factors
1
1996
3182
0.010
Why?

Visualizations


Kouides's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department